Drawing for GMAS

USPTO serial 86601678

GMAS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
POLLACK, ALISON FRIEDBERG
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GMAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Kim

KAREN KIM Menaker Herrmann10 E 40th St Fl 43New York, NY 10016-0354UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing business management information in connection with consulting and advisory services in the field of strategic planning; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodiesACTIVE—
042Conducting early evaluations in the field of new pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials, pharmacovigilance, medical research information services, pharmaceutical and biotechnology product development; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Product development consulting in the field of pharmaceuticals and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific study and research in the field(s) of pharmaceuticals and biotechnologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 6, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 6, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 15, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2016EX1GSOU EXTENSION 1 GRANTED—
Jun 13, 2016EXT1SOU EXTENSION 1 FILED—
Jun 13, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 5, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 10, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 21, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 6, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 5, 2015ALIEASSIGNED TO LIE—
Sep 8, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Sep 8, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 8, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 8, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 27, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2015DOCKASSIGNED TO EXAMINER—
Apr 28, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 21, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance